Results 111 to 120 of about 53,162 (283)

CORRELATION BETWEEN SGOT AND SGPT LEVELS WITH POSITIVE HBsAg LEVELS

Journal of Vocational Health Studies
Background: Serum Glutamic Oxaloacetate Transaminase (SGOT) and Serum Glutamic Pyruvic Transaminase (SGPT) are transaminase enzymes used to determine liver damage. The increase in both enzymes can indicate the level of liver cell damage.
Nisa'ur Rosyidah, Erlinda Widyastuti, Annisa Auliya Rahman, Nur Septia Handayani, Belgis   +4 more
doaj   +1 more source

Bulevirtide Monotherapy or in Combination for Chronic Hepatitis Delta: 2025 Update. [PDF]

J Viral Hepat
ABSTRACT Chronic hepatitis Delta (CHD) represents the most aggressive form of viral hepatitis. In the latest estimates, published in 2024 by the Polaris Observatory, the overall prevalence of the hepatitis Delta virus (HDV) in Hepatitis B surface antigen (HBsAg) + patients was estimated to be 2% worldwide, a lower figure than what was previously ...
Lampertico P, Anolli MP, Steppich K, Wedemeyer H.   +3 more
europepmc   +2 more sources

Low prevalence of hepatitis B and C among tuberculosis patients in Duhok Province, Kurdistan: Are HBsAg and anti-HCV prerequisite screening parameters in tuberculosis control program?

, 2016
Muayad Aghali Merza, Safer M. Haji, Abid Mohialdeen Hasan Alsharafani, Shivan U. Muhammed   +3 more
openalex   +1 more source

AB0336 Hepatitis b virus reactivation in rheumatoid arthritis patients with hbsag-negative/anti-hbc-positive status [PDF]

, 2018
Chup-Hei HO, Moon-Ho Leung
openalex   +1 more source

Hepatitis B Virus Infection in Vaccinated Children and Adolescents with HBsAg-positive Parents: Is Routine Vaccination Sufficient? [PDF]

, 2022
Alireza Bakhshipour, Manijeh Khalili, Raheleh Rafaiee   +2 more
openalex   +1 more source

B‐EPIC: A Transformer‐Based Language Model for Decoding B Cell Immunodominance Patterns

Advanced Science, Volume 12, Issue 47, December 18, 2025.
B‐Epic: Achieving high‐accuracy B cell epitope prediction through Transformer architecture. Comprehensive validation demonstrates B‐Epic's robust performance across diverse datasets. B‐Epic facilitates vaccine development for H. pylori and EBV, addressing critical public health challenges.
Jun‐Ze Liang, Youtao Wang, Cong Sun, Tao Liu, Zengfeng Wu, Lipeng Chen, Lina Chen, Penglin Li, Zhengkang Li, Cangui Zhang, Bingyun Lu, Ye Chen, Bing Gu, Qian Zhong, Xin Wei Wang, Mu‐Sheng Zeng, Jinping Liu   +16 more
wiley   +1 more source

A Male-ABCD Algorithm for Hepatocellular Carcinoma Risk Prediction in HBsAg Carriers [PDF]

, 2021
Yuting Wang, Minjie Wang, He Li, Kun Chen, Hongmei Zeng, Xinyu Bi, Zheng Zhu, Yuchen Jiao, Yong Wang, Jian Zhu, Huijun Zhao, Xiang Liu, Chunyun Dai, Chunsun Fan, Can Zhao, Deyin Guo, Hong Zhao, Sizhen Wang, Jianguo Zhou, Dongmei Wang, Zhiyuan Wu, Xinming Zhao, Wei Cui, Xuehong Zhang, Jianqiang Cai, Wanqing Chen, Chunfeng Qu   +26 more
openalex   +1 more source

Silica Nanoparticles as Multifunctional Platforms for Vaccine Delivery and Immune Modulation in Infectious Diseases

Advanced NanoBiomed Research, Volume 5, Issue 12, December 2025.
Overview of the use of silica nanoparticles in vaccines against pathogens. Different kinds of vaccines against infectious diseases are currently using solid or mesoporous silica nanoparticles in their formulation. Silica microparticles and nanoparticles (SiNPs) have been studied as vehicles for vaccines.
Noe Juvenal Mendoza‐Ramírez, Julio García‐Cordero, Gabriela Navarro‐Tovar, Leticia Cedillo‐Barrón   +3 more
wiley   +1 more source

Использование количественного определения HBsAg для мониторинга естественного течения хронической HBV-инфекции

, 2020
И.А. Зайцев
openalex   +2 more sources

Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy [PDF]

, 2001
Giuseppe Rossi, Annamaria Pelizzari, Maddalena Motta, Massimo Puoti   +3 more
openalex   +1 more source